Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 2 |
2015 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
Nat Chem Biol. 2014 Apr;10(4):305-12. doi: 10.1038/nchembio.1471. Epub 2014 Mar 2.
Nat Chem Biol. 2014.
PMID: 24584101
Free PMC article.
FLT3 D835 mutations confer differential resistance to type II FLT3 inhibitors.
Smith CC, Lin K, Stecula A, Sali A, Shah NP.
Smith CC, et al.
Leukemia. 2015 Dec;29(12):2390-2. doi: 10.1038/leu.2015.165. Epub 2015 Jun 25.
Leukemia. 2015.
PMID: 26108694
Free PMC article.
Item in Clipboard
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD.
Smith CC, Lasater EA, Zhu X, Lin KC, Stewart WK, Damon LE, Salerno S, Shah NP.
Smith CC, et al.
Blood. 2013 Apr 18;121(16):3165-71. doi: 10.1182/blood-2012-07-442871. Epub 2013 Feb 21.
Blood. 2013.
PMID: 23430109
Free PMC article.
Item in Clipboard
Computer aided drug discovery of highly ligand efficient, low molecular weight imidazopyridine analogs as FLT3 inhibitors.
Frett B, McConnell N, Smith CC, Wang Y, Shah NP, Li HY.
Frett B, et al.
Eur J Med Chem. 2015 Apr 13;94:123-31. doi: 10.1016/j.ejmech.2015.02.052. Epub 2015 Feb 28.
Eur J Med Chem. 2015.
PMID: 25765758
Free PMC article.
Item in Clipboard
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.
Smith CC, Zhang C, Lin KC, Lasater EA, Zhang Y, Massi E, Damon LE, Pendleton M, Bashir A, Sebra R, Perl A, Kasarskis A, Shellooe R, Tsang G, Carias H, Powell B, Burton EA, Matusow B, Zhang J, Spevak W, Ibrahim PN, Le MH, Hsu HH, Habets G, West BL, Bollag G, Shah NP.
Smith CC, et al.
Cancer Discov. 2015 Jun;5(6):668-79. doi: 10.1158/2159-8290.CD-15-0060. Epub 2015 Apr 6.
Cancer Discov. 2015.
PMID: 25847190
Free PMC article.
Item in Clipboard
Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy.
Warkentin AA, Lopez MS, Lasater EA, Lin K, He BL, Leung AY, Smith CC, Shah NP, Shokat KM.
Warkentin AA, et al.
Elife. 2014 Dec 22;3:e03445. doi: 10.7554/eLife.03445.
Elife. 2014.
PMID: 25531068
Free PMC article.
Item in Clipboard
Cite
Cite